Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38
United States Fiscal year ends December CIK 0001517022 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
4.7×

John P. Butler holds only 4.7 times base salary in stock. $4.13M of shares against $864.01K in salary for 2025.

Salary from the company's own proxy. The shares are what John P. Butler last reported holding, valued at $1.11, the price Common Stock was last bought or sold at on the open market here, on 29 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
John P. Butler
CEO and President
—
—
—
3,718,564
$4.13M
+68.1%
Steven Keith Burke
SVP, Chief Medical Officer
—
—
—
948,432
$1.05M
+40.5%
Erik Ostrowski
SVP, CFO, CBO & Treasurer
—
—
—
616,616
$684.44K
+76.2%
Carolyn M. Rucci
SVP, Chief Legal Officer
—
—
—
588,378
$653.10K
+25.7%
Nicholas Grund
Chief Commercial Officer
—
—
—
561,750
$623.54K
+85.2%
Richard C Malabre
SVP, Chief Accounting Officer
—
—
—
299,390
$332.32K
+31.1%
Adrian Adams
Director
—
—
—
236,200
$262.18K
+43.3%
Michael W Rogers
Director
—
—
—
197,429
$219.15K
+56.7%
Cynthia Smith
Director
—
—
—
196,633
$218.26K
+57.0%
Myles Wolf
Director
—
—
—
169,081
$187.68K
+73.1%
Ron Frieson
Director
—
—
—
165,200
$183.37K
+124.2%
Steven C Gilman
Director
—
—
—
152,830
$169.64K
+30.5%
Leanne M Zumwalt
Director
—
—
—
145,100
$161.06K
+96.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.